XIAO LING LIU
Massage Therapy at Colden St, Flushing, NY
License number
Florida 85456
Issued Date
Mar 1, 2017
Effective Date
Mar 1, 2017
Expiration Date
Aug 31, 2019
Category
Health Care
Type
Massage Therapist
Address
Address
4255 Colden St APT 10 K, Flushing, NY 11355
Phone
(646) 255-8157
Professional information
Methods And Compositions For Treating Psoriasis
US Patent:
2012007, Mar 22, 2012
Filed:
Sep 21, 2011
Appl. No.:
13/239230
Inventors:
Longgui Wang - Flushing NY, US
Xiao Mei Liu - Flushing NY, US
Simon K. Mencher - New York NY, US
Xiao Mei Liu - Flushing NY, US
Simon K. Mencher - New York NY, US
Assignee:
NATROGEN THERAPEUTICS INTERNATIONAL, INC. - New York NY
International Classification:
A61K 36/886, A61K 36/00, A61P 17/06, A61K 31/404
US Classification:
424744, 514414, 424725
Abstract:
The present invention is directed to topical compositions and methods for topically treating psoriasis comprising meisoindigo as an active ingredient. The topical compositions preferably further comprise skin penetration enhancers, pharmaceutical surfactants and solubility enhancers, oil phase components, aqueous phase components, emulsifiers, moisturizers, antioxidants, vitamins, lubricants, herbal extracts, preservatives, and other ingredients. In addition to meisoindigo, the compositions may comprise other agents commonly used to topically treat psoriasis. The disclosed methods have been demonstrated to effectually treat moderate and severe forms of psoriasis to a degree similar to a potent corticosteroid without side effects. Preferably, the method involves topical application of the disclosed compositions to affected epidermal areas twice a day. In addition, the disclosed methods may be used in conjunction with other common therapies in the treatment of psoriasis.
Method Of Treating Inflammatory Arthritis
US Patent:
7855223, Dec 21, 2010
Filed:
Jul 26, 2006
Appl. No.:
11/494362
Inventors:
Ruihuan Chen - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Allen Tsao - Windlake WI, US
Xiao Mei Liu - Flushing NY, US
Longgui Wang - Flushing NY, US
Simon K. Mencher - New York NY, US
Allen Tsao - Windlake WI, US
Xiao Mei Liu - Flushing NY, US
Longgui Wang - Flushing NY, US
Assignee:
Natrogen Therapeutics International, Inc. - New York NY
International Classification:
A61K 31/40, A61K 31/405, A61K 31/56, A61K 31/19
US Classification:
514414, 514415, 514416, 514 23, 514159, 514171, 514570, 51425409
Abstract:
The present invention is directed to a method for treating inflammatory arthritis in a mammal. The method typically comprises administering to an animal a therapeutically effective amount of at least one compound selected from indigo, isoindigo, indirubin or derivatives thereof, such as NATURA-α or NATURA. The present invention is further directed to pharmaceutical compositions that include a therapeutically effective amount of at least one compound of the invention, an anti-inflammatory arthritis agent and a pharmaceutically acceptable carrier.
Methods Of Treating An Inflammatory-Related Disease
US Patent:
2013017, Jul 11, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/791314
Inventors:
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Assignee:
NATROGEN THERAPEUTICS INTERNATIONAL INC. - New York NY
International Classification:
A61K 31/404, A61K 45/00, A61K 31/7056
US Classification:
514 43, 514414
Abstract:
The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.
Methods Of Treating An Inflammatory-Related Disease
US Patent:
7582670, Sep 1, 2009
Filed:
Apr 13, 2005
Appl. No.:
11/104422
Inventors:
Longgui Wang - Flushing NY, US
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Assignee:
Natrogen Therapeutics, Inc. - Milwaukee WI
International Classification:
A61K 31/40, A61K 31/404, A61K 31/56
US Classification:
514414, 514415, 514416, 514406, 514171, 51425409, 514570, 514159
Abstract:
The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.
Methods Of Treating An Inflammatory-Related Disease
US Patent:
8394847, Mar 12, 2013
Filed:
Aug 26, 2009
Appl. No.:
12/548083
Inventors:
Longgui Wang - Flushing NY, US
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Assignee:
Natrogen Therapeutics International, Inc. - New York NY
International Classification:
A01N 43/38, A01N 43/12, A01N 43/06, A61K 31/40, A61K 31/38, A61K 31/105
US Classification:
514414, 514415, 514412, 514443, 514448, 514421
Abstract:
The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.
Methods Of Treating An Inflammatory-Related Disease
US Patent:
8563525, Oct 22, 2013
Filed:
Dec 20, 2010
Appl. No.:
12/972908
Inventors:
Longgui Wang - Flushing NY, US
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Xiao Mei Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon K. Mencher - New York NY, US
Assignee:
Natrogen Therapeutics International, Inc. - New York NY
International Classification:
A61P 1/00, A61P 25/28, A61P 29/00, A61P 19/02
US Classification:
514 43, 514414
Abstract:
The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA in an amount less than sufficient to inhibit CDKs.
Methods Of Treating An Inflammatory-Related Disease
US Patent:
2005015, Jul 14, 2005
Filed:
Jan 12, 2004
Appl. No.:
10/754547
Inventors:
Longgui Wang - Flushing NY, US
Xiao Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon Mencher - New York NY, US
James McCarron - New York NY, US
Xiao Liu - Flushing NY, US
Lian Mo - Palo Alto CA, US
Simon Mencher - New York NY, US
James McCarron - New York NY, US
International Classification:
A61K031/404
US Classification:
514414000
Abstract:
The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.